文献速递免疫规划传染病防控与疫情报告

魁北克省使用三种不同肺炎球菌结合疫苗前后侵袭性肺炎球菌疾病的发病率

Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
PubMed 文献 · Vaccine · 2017-12-07

魁北克省儿童按2+1剂次程序先后使用7价、10价和13价肺炎球菌结合疫苗。分析监测数据发现,5岁以下儿童侵袭性肺炎球菌疾病发病率从2003年的69/10万降至2016年的12/10万(降幅83%);成人总体发病率未下降,但疫苗血清型分布发生替换。

要点

  • 5岁以下儿童侵袭性肺炎球菌疾病发病率从2003年69/10万降至2016年12/10万,降幅83%。
  • PCV13血清型3在2011-2016年接种PCV13儿童中,10例中6例发生于加强剂后超过1年,提示短期保护。
  • 31例19A型突破病例中19例为8-14月龄儿童,已接种2剂PCV13基础剂但未接种幼儿加强剂。

核心结论

  • 肺炎球菌结合疫苗对儿童侵袭性肺炎球菌疾病发病率有重大影响,但对成人无影响。
  • 老年成人中PCV13血清型所致病例比例逐年下降,但多数病例仍被23价多糖疫苗覆盖。

研究设计与样本

  • 分析魁北克省法定报告和实验室监测数据,并核查儿童侵袭性肺炎球菌疾病病例的免疫接种状态。
  • 儿童按2+1剂次程序先后使用PCV7、PCV10和PCV13。

主要发现

  • 5岁以下儿童侵袭性肺炎球菌疾病发病率从2003年69/10万降至2016年12/10万,降幅83%。
  • 2004年引入PCV7后,PCV7型病例和6A型迅速下降;7F和19A型出现,但在2009年引入PCV10和2011年引入PCV13后发病率下降;血清型3的下降幅度 modest。
  • 非PCV13型增加,2016年占病例的79%。
  • 成人中观察到相同模式,但血清型替换完全,总体侵袭性肺炎球菌疾病发病率无下降。
  • 65岁及以上成人中,2016年PCV13血清型占病例的28%,62%为23价多糖疫苗包含的血清型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In Quebec, 7-valent (PCV7), 10-valent (PCV10) and 13-valent (PCV13) pneumococcal conjugate vaccines were successively used for the immunization of children according to a 2+1 doses schedule. OBJECTIVE: Our aim was to assess the impact of this program on the epidemiology of invasive pneumococcal disease (IPD) in children and adults. METHODS: Notification and laboratory surveillance data were analyzed and the immunization status of IPD cases in children was checked. RESULTS: In children < 5 years, the IPD rate decreased from 69/100,000 in 2003 to 12/100,000 in 2016 (83% reduction). Following PCV7 introduction in 2004, there has been a rapid decline in PCV7-type IPD cases and 6A. 7F and 19A serotypes emerged but their incidence decreased following PCV10 introduction in 2009 and PCV13 in 2011, whereas decrease in serotype 3 IPD was modest. Non-PCV13 types increased and represented 79% of cases in 2016. The same pattern was seen in adults but replacement was complete and there was no decrease in overall IPD rate. In those 65 years and over, PCV13 serotypes represented 28% of cases in 2016 and 62% were serotypes included in the 23-valent polysaccharide vaccine. Out of 10 IPD cases caused by serotype 3 in children vaccinated with PCV13 in 2011-2016, 6 occurred more than one year following the booster dose, which suggests short-term protection. Out of 31 breakthrough 19A cases, 19 occurred in children aged between 8 and 14 months who had received the 2 primary PCV13 doses but not the toddler booster dose, which suggests a window of susceptibility in a 2+1 schedule. CONCLUSION: PCVs had a major impact on the IPD rate in children but not in adults. Among elderly adults, the proportion of cases caused by serotypes included in PCV13 is diminishing year after year but a majority of cases remains covered by the 23-valent polysaccharide vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. De Wals P, Lefebvre B, Deceuninck G, et al. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec. Vaccine. 2017. PMID: 29224962. doi:10.1016/j.vaccine.2017.11.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。